- Report
- April 2024
- 132 Pages
Global
From €865EUR$950USD£734GBP
- Book
- July 2018
- 106 Pages
- Report
- December 2023
- 325 Pages
Global
From €2275EUR$2,499USD£1,932GBP
€3249EUR$3,570USD£2,760GBP
- Report
- August 2022
- 329 Pages
Global
From €2351EUR$2,583USD£1,997GBP
€3359EUR$3,690USD£2,853GBP
- Report
- March 2022
- 264 Pages
Global
From €2365EUR$2,598USD£2,009GBP
€3379EUR$3,712USD£2,870GBP
- Report
- July 2021
- 295 Pages
Global
From €2365EUR$2,598USD£2,009GBP
€3379EUR$3,712USD£2,870GBP
- Book
- February 2018
- 864 Pages
The In Vitro Assay market is a segment of the biotechnology industry that focuses on the development and production of laboratory tests and instruments used to detect and measure biological molecules. These assays are used to study the function of genes, proteins, and other molecules in a variety of biological processes. In vitro assays are used to study the effects of drugs, toxins, and other compounds on cells and tissues, as well as to diagnose and monitor diseases.
In vitro assays are used in a wide range of applications, including drug discovery and development, diagnostics, and research. They are also used in the production of biopharmaceuticals, such as vaccines and monoclonal antibodies.
Some of the major companies in the In Vitro Assay market include Thermo Fisher Scientific, Merck KGaA, Agilent Technologies, Bio-Rad Laboratories, PerkinElmer, and Roche Diagnostics. Show Less Read more